Wnt/β-catenin-driven EMT Regulation in Human Cancers

Overview

Journal Cell Mol Life Sci

Publisher Springer

Specialty Biology

Date 2024 Feb 9

PMID 38334836

Authors

Wenhua Xue

Lin Yang

Chengxin Chen

Milad Ashrafizadeh

Yu Tian

Ranran Sun

Affiliations

Soon will be listed here.

Abstract

Metastasis accounts for 90% of cancer-related deaths among the patients. The transformation of epithelial cells into mesenchymal cells with molecular alterations can occur during epithelial-mesenchymal transition (EMT). The EMT mechanism accelerates the cancer metastasis and drug resistance ability in human cancers. Among the different regulators of EMT, Wnt/β-catenin axis has been emerged as a versatile modulator. Wnt is in active form in physiological condition due to the function of GSK-3β that destructs β-catenin, while ligand-receptor interaction impairs GSK-3β function to increase β-catenin stability and promote its nuclear transfer. Regarding the oncogenic function of Wnt/β-catenin, its upregulation occurs in human cancers and it can accelerate EMT-mediated metastasis and drug resistance. The stimulation of Wnt by binding Wnt ligands into Frizzled receptors can enhance β-catenin accumulation in cytoplasm that stimulates EMT and related genes upon nuclear translocation. Wnt/β-catenin/EMT axis has been implicated in augmenting metastasis of both solid and hematological tumors. The Wnt/EMT-mediated cancer metastasis promotes the malignant behavior of tumor cells, causing therapy resistance. The Wnt/β-catenin/EMT axis can be modulated by upstream mediators in which non-coding RNAs are main regulators. Moreover, pharmacological intervention, mainly using phytochemicals, suppresses Wnt/EMT axis in metastasis suppression.

Citing Articles

SATB1 in cancer progression and metastasis: mechanisms and therapeutic potential.

Bai J, Yang G, Yu Q, Chi Q, Zeng X, Qi W Front Oncol. 2025; 15:1535929.

PMID: 40071088 PMC: 11893431. DOI: 10.3389/fonc.2025.1535929.

[C6TSEDRVAJZ, a combination of small-molecule compounds, induces differentiation of human placental fibroblasts into epithelioid cells ].

Dai Z, Gao Q, Ying M, Wang A, Hong J, Wang C Nan Fang Yi Ke Da Xue Xue Bao. 2025; 45(2):322-330.

PMID: 40031976 PMC: 11875853. DOI: 10.12122/j.issn.1673-4254.2025.02.13.

Acetyltransferase NAT10 promotes gastric cancer progression by regulating the Wnt/β-catenin signaling pathway and enhances chemotherapy resistance.

Chen Y, Yang J, Du Y, Yan Z, Gao J, Zhang H Discov Oncol. 2025; 16(1):173.

PMID: 39945932 PMC: 11825422. DOI: 10.1007/s12672-025-01917-5.

Long Non-Coding RNAs: Key Regulators of Tumor Epithelial/Mesenchymal Plasticity and Cancer Stemness.

Yuan Y, Tang Y, Fang Z, Wen J, Wicha M, Luo M Cells. 2025; 14(3).

PMID: 39937018 PMC: 11817775. DOI: 10.3390/cells14030227.

CircRNA circACTN4 Promotes the Progression of Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma by Targeting the miR-424-5p/NCAPG/Wnt Axis.

Shan J, Pu J, Chen X, Zhang Y, Li J, Qin L Clin Exp Med. 2025; 25(1):47.

PMID: 39891781 PMC: 11787268. DOI: 10.1007/s10238-025-01573-7.

References

Jung Y, Park J . Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex. Exp Mol Med. 2020; 52(2):183-191. PMC: 7062731. DOI: 10.1038/s12276-020-0380-6. View

Chong Seow Khoon M . Experimental models of bone metastasis: Opportunities for the study of cancer dormancy. Adv Drug Deliv Rev. 2015; 94:141-50. DOI: 10.1016/j.addr.2014.12.007. View

Su H, Lai H, Lin Y, Liu C, Chen C, Chou Y . Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway. Int J Cancer. 2009; 127(3):555-67. DOI: 10.1002/ijc.25083. View

Chen M, Wu X, Ma W, Zhou Q, Wang X, Zhang R . Decreased expression of lncRNA VPS9D1-AS1 in gastric cancer and its clinical significance. Cancer Biomark. 2017; 21(1):23-28. DOI: 10.3233/CBM-170172. View

Wen J, Zhao Z, Huang L, Wang L, Miao Y, Wu J . IL-8 promotes cell migration through regulating EMT by activating the Wnt/β-catenin pathway in ovarian cancer. J Cell Mol Med. 2019; 24(2):1588-1598. PMC: 6991660. DOI: 10.1111/jcmm.14848. View

Shalev N, Kendall M, Anil S, Tiwari S, Peeri H, Kumar N . Phytocannabinoid Compositions from Cannabis Act Synergistically with PARP1 Inhibitor against Ovarian Cancer Cells In Vitro and Affect the Wnt Signaling Pathway. Molecules. 2022; 27(21). PMC: 9653955. DOI: 10.3390/molecules27217523. View

Kruk I, Michalska T, Lichszteld K, Kladna A, Aboul-Enein H . The effect of thymol and its derivatives on reactions generating reactive oxygen species. Chemosphere. 2000; 41(7):1059-64. DOI: 10.1016/s0045-6535(99)00454-3. View

Breuer E, Fukushiro-Lopes D, Dalheim A, Burnette M, Zartman J, Kaja S . Potassium channel activity controls breast cancer metastasis by affecting β-catenin signaling. Cell Death Dis. 2019; 10(3):180. PMC: 6385342. DOI: 10.1038/s41419-019-1429-0. View

Shi Y, Ge C, Fang D, Wei W, Li L, Wei Q . NCAPG facilitates colorectal cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition by activating the Wnt/β-catenin signaling pathway. Cancer Cell Int. 2022; 22(1):119. PMC: 8922890. DOI: 10.1186/s12935-022-02538-6. View

10.

Xing S, Kan J, Su A, Liu Q, Wang K, Cai X . The prognostic value of major facilitator superfamily domain-containing protein 2A in patients with hepatocellular carcinoma. Aging (Albany NY). 2019; 11(19):8474-8483. PMC: 6814593. DOI: 10.18632/aging.102333. View

11.

Ahmad S, Nayak D, Bashir Mir K, Faheem M, Nawaz S, Yadav G . Par-4 activation restrains EMT-induced chemoresistance in PDAC by attenuating MDM-2. Pancreatology. 2020; 20(8):1698-1710. DOI: 10.1016/j.pan.2020.09.021. View

12.

Liu W, Chen Y, Xie H, Guo Y, Ren D, Li Y . TIPE1 suppresses invasion and migration through down-regulating Wnt/β-catenin pathway in gastric cancer. J Cell Mol Med. 2017; 22(2):1103-1117. PMC: 5783849. DOI: 10.1111/jcmm.13362. View

13.

Ge Q, Hu Y, He J, Chen F, Wu L, Tu X . Zic1 suppresses gastric cancer metastasis by regulating Wnt/β-catenin signaling and epithelial-mesenchymal transition. FASEB J. 2020; 34(2):2161-2172. DOI: 10.1096/fj.201901372RR. View

14.

Li K, Zhan X, Sun J, Wang T, Dong H, Jing F . Oldhamianoside II inhibits prostate cancer progression via regulation of EMT and the Wnt/β-catenin signaling pathway. Oncol Lett. 2018; 15(6):9457-9463. PMC: 5958739. DOI: 10.3892/ol.2018.8450. View

15.

Yang S, Ma S, Dou H, Liu F, Zhang S, Jiang C . Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment. Exp Cell Res. 2020; 391(2):111983. DOI: 10.1016/j.yexcr.2020.111983. View

16.

Yang Y, Zhang N, Zhu J, Hong X, Liu H, Ou Y . Downregulated connexin32 promotes EMT through the Wnt/β-catenin pathway by targeting Snail expression in hepatocellular carcinoma. Int J Oncol. 2017; 50(6):1977-1988. PMC: 5435329. DOI: 10.3892/ijo.2017.3985. View

17.

Zhao M, Sun Y, Gao Z, Cui H, Chen J, Wang M . Gigantol Attenuates the Metastasis of Human Bladder Cancer Cells, Possibly Through Wnt/EMT Signaling. Onco Targets Ther. 2020; 13:11337-11346. PMC: 7649247. DOI: 10.2147/OTT.S271032. View

18.

Gallo A, Tandon M, Alevizos I, Illei G . The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One. 2012; 7(3):e30679. PMC: 3302865. DOI: 10.1371/journal.pone.0030679. View

19.

Gavas S, Quazi S, Karpinski T . Nanoparticles for Cancer Therapy: Current Progress and Challenges. Nanoscale Res Lett. 2021; 16(1):173. PMC: 8645667. DOI: 10.1186/s11671-021-03628-6. View

20.

Zhang P, Xu Y, Chen S, Wang Z, Zhao L, Chen C . ARL4C Regulates the Progression of Clear Cell Renal Cell Carcinoma by Affecting the Wnt/-Catenin Signaling Pathway. J Oncol. 2022; 2022:2724515. PMC: 9239764. DOI: 10.1155/2022/2724515. View